AI assistant
Sending…
Syndax Pharmaceuticals Inc — Director's Dealing 2021
Apr 28, 2021
31977_dirs_2021-04-28_23491817-ab5d-4f9f-872c-609be227cba6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Syndax Pharmaceuticals Inc (SNDX)
CIK: 0001395937
Period of Report: 2021-04-26
Reporting Person: Meyers Michael L. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-26 | Common Stock | P | 500.00 | $15.46 | Acquired | 15666.00 | Direct |
More from Syndax Pharmaceuticals Inc
Annual Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6